Is SUVmax Helpful in the Differential Diagnosis of Enlarged Mediastinal Lymph Nodes? A Pilot Study

Overview

Journal Contrast Media Mol Imaging

Specialty Radiology

Date 2018 Dec 5

PMID 30510493

Citations 8

Authors

Congcong Yu

Xiaotian Xia

Chunxia Qin

Xun Sun

Yongxue Zhang

Xiaoli Lan

Affiliations

Soon will be listed here.

Abstract

Objective: To explore the diagnostic value of maximum standard uptake value (SUVmax) from F-FDG PET/CT images in enlarged mediastinal lymph nodes of unknown etiology.

Methods: We performed a retrospective study of patients with enlarged mediastinal lymph nodes on F-FDG PET/CT scans. SUVmax and the short axis and long axis of lymph nodes were recorded. These parameters were compared among the five commonest causes of mediastinal lymphadenopathy: lymphoma, metastatic disease, sarcoidosis, tuberculosis, and lymphadenitis. Histopathologic diagnosis was recorded as the final golden standard.

Results: A total of 94 patients (62 men and 32 women; age range 7-85 y) were included with final diagnoses of 42 patients with benign pathology and 52 patients with malignancies. The sensitivity, specificity, and the accuracy of PET/CT in diagnosis of the benign and malignant mediastinal lymph nodes were 94.2%, 73.8%, and 85.1%, respectively. The SUVmax of benign and malignant groups were 13.10 ± 5.21 and 12.59 ± 5.50, respectively, which had no statistical difference ( > 0.05). However, the long axis and the short axis of lymph nodes in the benign and malignant groups were 2.86 ± 1.02 cm, 1.77 ± 0.60 cm and 6.04 ± 3.83 cm, 3.95 ± 2.08 cm, respectively ( < 0.05). The diagnostic values of PET/CT were higher than those of the long or short axis. However, the specificity of PET/CT was lower (73.8%) than that from the long or short axis (90.5% and 92.9%, respectively), although no statistical difference existed. Among the five common causes of mediastinal lymphadenopathy, significant differences could be seen in SUVmax and in the long axis and the short axis of lymph nodes ( < 0.05).

Conclusions: SUVmax, a commonly used semiquantitative measurement, was not helpful for differentiation between benign and malignant lesions in patients with enlarged mediastinal lymph nodes in this study. Many benign lesions, such as sarcoidosis and tuberculosis, had high FDG uptake, possibly a trend that the size of the lymph nodes seems to have some diagnostic value.

Citing Articles

Value of 18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the differential diagnosis of sarcoidosis and lung cancer with lymph node metastasis: a retrospective study.

Chen X, Xu X, Chrysikos S, Zhao M, Zhou Y Transl Lung Cancer Res. 2022; 11(9):1926-1935.

PMID: 36248335 PMC: 9554681. DOI: 10.21037/tlcr-22-611.

Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on F-FDG PET/MRI and Machine Learning.

Morawitz J, Sigl B, Rubbert C, Bruckmann N, Dietzel F, Haberle L J Nucl Med. 2022; 64(2):304-311.

PMID: 36137756 PMC: 9902847. DOI: 10.2967/jnumed.122.264138.

Distinction of Lymphoma from Sarcoidosis on F-FDG PET/CT: Evaluation of Radiomics-Feature-Guided Machine Learning Versus Human Reader Performance.

Lovinfosse P, Ferreira M, Withofs N, Jadoul A, Derwael C, Frix A J Nucl Med. 2022; 63(12):1933-1940.

PMID: 35589406 PMC: 9730930. DOI: 10.2967/jnumed.121.263598.

Neurosarcoidosis Mimicking the Recurrence of Malignant Lymphoma.

Murakami K, Koh J, Taruya J, Ito H Case Rep Neurol. 2021; 13(3):605-612.

PMID: 34703450 PMC: 8460933. DOI: 10.1159/000518378.

Role of Imaging in a Case of Toxoplasmosis Presenting as Generalized Lymphadenopathy.

Pratap T, Jalal M, K V, Raja S Indian J Radiol Imaging. 2021; 31(2):445-450.

PMID: 34556929 PMC: 8448221. DOI: 10.1055/s-0041-1734226.

References

Annema J, Versteegh M, Veselic M, Voigt P, Rabe K . Endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of lung cancer and its impact on surgical staging. J Clin Oncol. 2005; 23(33):8357-61. DOI: 10.1200/JCO.2005.01.1965. View

Konishi J, Yamazaki K, Tsukamoto E, Tamaki N, Onodera Y, Otake T . Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration. 2003; 70(5):500-6. DOI: 10.1159/000074207. View

Koukouraki S, Strauss L, Georgoulias V, Eisenhut M, Haberkorn U, Dimitrakopoulou-Strauss A . Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy. Eur J Nucl Med Mol Imaging. 2006; 33(10):1115-22. DOI: 10.1007/s00259-006-0110-x. View

Rizzo G, Castiglioni I, Russo G, Tana M, dellAcqua F, Gilardi M . Using deconvolution to improve PET spatial resolution in OSEM iterative reconstruction. Methods Inf Med. 2007; 46(2):231-5. View

Kumar A, Dutta R, Kannan U, Kumar R, Khilnani G, Gupta S . Evaluation of mediastinal lymph nodes using F-FDG PET-CT scan and its histopathologic correlation. Ann Thorac Med. 2011; 6(1):11-6. PMC: 3023864. DOI: 10.4103/1817-1737.74270. View

Luo M, Liu L, Lai L, Dong Y, Liang W, Qin J . Deepgoing study on intrathoracic tuberculous lymphadenitis in adults using multidetector CT. Chin Med J (Engl). 2010; 123(10):1283-8. View

Li X, Zhang H, Xing L, Ma H, Xie P, Zhang L . Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study. Radiother Oncol. 2011; 102(2):246-50. DOI: 10.1016/j.radonc.2011.10.016. View

Antoch G, Vogt F, Freudenberg L, Nazaradeh F, Goehde S, Barkhausen J . Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA. 2003; 290(24):3199-206. DOI: 10.1001/jama.290.24.3199. View

Xiong L, Mao X, Li C, Liu Z, Zhang Z . Posterior mediastinal tuberculous lymphadenitis with dysphagia as the main symptom: a case report and literature review. J Thorac Dis. 2013; 5(5):E189-94. PMC: 3815737. DOI: 10.3978/j.issn.2072-1439.2013.09.03. View

10.

Rohren E, Turkington T, Coleman R . Clinical applications of PET in oncology. Radiology. 2004; 231(2):305-32. DOI: 10.1148/radiol.2312021185. View

11.

Takamochi K, Yoshida J, Murakami K, Niho S, Ishii G, Nishimura M . Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Lung Cancer. 2005; 47(2):235-42. DOI: 10.1016/j.lungcan.2004.08.004. View

12.

Jarritt P, Carson K, Hounsell A, Visvikis D . The role of PET/CT scanning in radiotherapy planning. Br J Radiol. 2006; 79 Spec No 1:S27-35. DOI: 10.1259/bjr/35628509. View

13.

Lan X, Zhang Y, Wu Z, Jia Q, Wei H, Gao Z . The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions. Clin Radiol. 2008; 63(7):756-64. DOI: 10.1016/j.crad.2008.01.003. View

14.

Venkateswaran R, Barron D, Brawn W, Clarke J, Desai M, Samuel M . A forgotten old disease: mediastinal tuberculous lymphadenitis in children. Eur J Cardiothorac Surg. 2005; 27(3):401-4. DOI: 10.1016/j.ejcts.2004.12.014. View

15.

Berghmans T, Dusart M, Paesmans M, Hossein-Foucher C, Buvat I, Castaigne C . Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the.... J Thorac Oncol. 2008; 3(1):6-12. DOI: 10.1097/JTO.0b013e31815e6d6b. View

16.

Cerfolio R, Bryant A . Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal (N2) lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with nonsmall-cell lung cancer. Ann Thorac Surg. 2007; 83(5):1826-9. DOI: 10.1016/j.athoracsur.2006.12.034. View

17.

Yap C, Schiepers C, Fishbein M, Phelps M, Czernin J . FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?. Eur J Nucl Med Mol Imaging. 2002; 29(9):1166-73. DOI: 10.1007/s00259-002-0853-y. View

18.

Scimeca M, Urbano N, Bonfiglio R, Schillaci O, Bonanno E . Management of oncological patients in the digital era: anatomic pathology and nuclear medicine teamwork. Future Oncol. 2018; 14(11):1013-1015. DOI: 10.2217/fon-2017-0698. View

19.

Herth F, Eberhardt R, Krasnik M, Ernst A . Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer. Chest. 2008; 133(4):887-91. DOI: 10.1378/chest.07-2535. View

20.

Kim S, Allen-Auerbach M, Goldin J, Fueger B, Dahlbom M, Brown M . Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med. 2007; 48(2):214-20. View